Free Trial

Synthomer (LON:SYNT) Shares Pass Below 200-Day Moving Average - Time to Sell?

Synthomer logo with Basic Materials background

Synthomer plc (LON:SYNT - Get Free Report) crossed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of GBX 126.81 ($1.72) and traded as low as GBX 108.80 ($1.47). Synthomer shares last traded at GBX 114.60 ($1.55), with a volume of 182,693 shares.

Analysts Set New Price Targets

Separately, Berenberg Bank cut Synthomer to a "hold" rating and dropped their price target for the company from GBX 230 ($3.12) to GBX 150 ($2.03) in a research note on Wednesday, March 12th.

Read Our Latest Stock Report on SYNT

Synthomer Trading Up 3.8%

The stock has a market capitalization of £195.13 million, a P/E ratio of -2.38, a P/E/G ratio of -0.17 and a beta of 1.79. The company has a current ratio of 1.90, a quick ratio of 0.97 and a debt-to-equity ratio of 78.27. The business has a 50-day moving average price of GBX 94.63 and a two-hundred day moving average price of GBX 126.81.

Synthomer (LON:SYNT - Get Free Report) last released its quarterly earnings data on Wednesday, March 12th. The company reported GBX (3.50) (($0.05)) earnings per share for the quarter. Synthomer had a negative net margin of 4.40% and a negative return on equity of 7.52%. On average, analysts expect that Synthomer plc will post 12.962963 EPS for the current fiscal year.

Synthomer Company Profile

(Get Free Report)

Synthomer plc is a leading supplier of high-performance, highly specialised polymers and ingredients that play vital roles in key sectors such as coatings, construction, adhesives, and health and protection – growing markets for customers who serve billions of end users worldwide. Headquartered in London, UK and listed on the LSE since 1971, we employ c.4,000 employees across our five innovation centres of excellence and 30 manufacturing sites across Europe, North America, Middle East and Asia.

Featured Articles

Should You Invest $1,000 in Synthomer Right Now?

Before you consider Synthomer, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synthomer wasn't on the list.

While Synthomer currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Analysts Are Watching These 4 Penny Stocks—You Should Too
Congress Is Pouring Millions Into These 6 Surprising Stocks
3 Dirt-Cheap Stocks in a Market That’s Getting Expensive

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines